0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover666.29%IV-58.16%PremiumJul 19, 2024Expiry Date2.78Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9311Delta0.0344Gamma1.62Leverage Ratio-0.0478Theta0.0002Rho1.51Eff Leverage0.0008Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet